Increased plasma VWF levels in patients with COVID-19 were observed in many studies, and their correlation with the disease severity and mortality suggests their important role in the pathogenesis of thrombosis in COVID-19 [21]. The gene discussed is VWF; the disease is Venous thrombosis.